Testing effectiveness (Phase 2)UnknownNCT04397497
What this trial is testing
Mavrilimumab in Severe COVID-19 Pneumonia and Hyper-inflammation (COMBAT-19)
Who this might be right for
Covid-19Acute Respiratory FailureARDS, Human+2 more
Ospedale San Raffaele 50